novo nordisk glp 1 agonist GLP-1 analogs, new trend in obesity treatment, become even more effective < Pharma < Article GLP-1 RA education
Description
GLP-1s claimed the top two spots in 2024 drug spending and accounted for more than one-third of the top 10 drugs overall.
Discover how GLP-1 receptor agonists like semaglutide may reduce inflammation beyond blood sugar control
This novel drug offe
Further studies are needed to assess the potential cardiovascular and renal benefits of combination therapy and to determine suitable patient population for the therapy
